Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Idexx Laboratories (NQ: IDXX )

491.03 +2.89 (+0.59%)
Streaming Delayed Price Updated: 9:39 AM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,845
Open 495.20
Bid (Size) 489.62 (4)
Ask (Size) 491.56 (2)
Prev. Close 488.14
Today's Range 491.01 - 495.56
52wk Range 317.06 - 560.92
Shares Outstanding 85,075,932
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations for IDEXX Laboratories's Future
 
Via Benzinga
$1000 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga

Performance

YTD
+20.94%
+20.94%
1 Month
+4.88%
+4.88%
3 Month
+21.30%
+21.30%
6 Month
+48.92%
+48.92%
1 Year
-8.99%
-8.99%

More News

Read More
What Does IDEXX Laboratories' Debt Look Like?
Via Benzinga
A Look Into IDEXX Laboratories' Debt
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,500 Today
Via Benzinga
Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead
Via MarketBeat
2 Top Healthcare Stocks to Buy Right Now
Via The Motley Fool
Where IDEXX Laboratories Stands With Analysts
Via Benzinga
Here's How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today
Via Benzinga
A Preview Of IDEXX Laboratories's Earnings
Via Benzinga
Golden Cross Appears Before IDEXX Laboratories Investors
Via Benzinga
2 Top Stocks I'm Buying Hand Over Fist in February
Via The Motley Fool
Analyst Says IDEXX Laboratories' Long-Term Growth Outlook Remains Strong
Via Benzinga
Earnings Scheduled For February 6, 2023
Via Benzinga
Morgan Stanley Maintains Overweight Rating for IDEXX Laboratories: Here's What You Need To Know
Via Benzinga
Five Best And Worst Performing Healthcare Stocks In January 2023
Via Talk Markets
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
Via Investor's Business Daily
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
Via Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
Via Investor's Business Daily
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
Via Investor's Business Daily
GE HealthCare Technologies Soars As GE Legacy Business Plummets
Via MarketBeat
Topics Stocks
Exposures US Equities
What Does IDEXX Laboratories' Debt Look Like?
Via Benzinga
3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023
Via The Motley Fool
Looking Into IDEXX Laboratories's Return On Capital Employed
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.